Pew Responds to White House's Drug Pricing Blueprint Information Request

Comments address administration’s questions on how federal, manufacturer programs affect spending

The Pew Charitable Trusts sent a letter July 16 to the U.S. Department of Health and Human Services, offering comments on the Trump administration’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Request for Information (RFI).

Pew’s response to the RFI addresses the following topics:

  • Federal program incentives.
  • Drug pricing structures and incentives.
  • Proposals to reform the Medicare Part B Competitive Acquisition Program.
  • Price reporting requirements and incentive structures.
  • Cost-shifting and cross-subsidization.
  • Generic drug pricing and development.
  • Pharmacy benefit managers and rebates.
  • 340B Drug Pricing Program.
  • Patient cost-sharing.
The front facade of the Supreme Court of the United States in Washington, DC.

Agenda for America

A collection of resources to help federal, state, and local decision-makers set an achievable agenda for all Americans

Quick View

Data-driven policymaking is not just a tool for finding new solutions for emerging challenges, it makes government more effective and better able to serve the public interest. In the coming months, President Joe Biden and the 117th Congress will tackle a number of environmental, health, public safety, and fiscal and economic issues—nearly all of them complicated by the COVID-19 pandemic. To help solve specific, systemic problems in a nonpartisan fashion, Pew has compiled a series of briefings and recommendations based on our research, technical assistance, and advocacy work across America.


States of Innovation

Data-driven state policy innovations across America

Quick View

Data-driven policymaking is not just a tool for finding new solutions for difficult challenges. When states serve their traditional role as laboratories of innovation, they increase the American people’s confidence that the government they choose—no matter the size—can be effective, responsive, and in the public interest.